Top Iovance Biotherapeutics, Inc Presentations
The most viewed presentations, reports, and documents from Iovance Biotherapeutics, Inc.
Iovance TIL Cell Therapy Solid Tumors 2021
investor_presentationinvestor_presentation
50 Pages
Iovance Biotherapeutics Investor Presentation — February 2018
investor_presentationinvestor_presentation
42 Pages
Iovance Biotherapeutics Investor Presentation — January 2019
investor_presentationinvestor_presentation
34 Pages
Iovance Biotherapeutics Investor Presentation — January 2019
investor_presentationinvestor_presentation
34 Pages
Iovance Biotherapeutics Investor Presentation — February 2019
investor_presentationinvestor_presentation
35 Pages
Iovance Biotherapeutics Investor Presentation — March 2019
investor_presentationinvestor_presentation
27 Pages
Iovance Biotherapeutics Investor Presentation — April 2019
investor_presentationinvestor_presentation
35 Pages
Iovance Biotherapeutics Investor Presentation — April 2019
investor_presentationinvestor_presentation
26 Pages
Iovance Biotherapeutics Investor Presentation — June 2019
investor_presentationinvestor_presentation
37 Pages
Iovance Biotherapeutics Investor Presentation — June 2019
investor_presentationinvestor_presentation
24 Pages
Iovance Biotherapeutics Investor Presentation — September 2019
investor_presentationinvestor_presentation
39 Pages
Iovance Biotherapeutics Investor Presentation — October 2019
investor_presentationinvestor_presentation
39 Pages
Iovance Biotherapeutics Investor Presentation — October 2019
investor_presentationinvestor_presentation
41 Pages
Iovance Biotherapeutics Investor Presentation — February 2021
investor_presentationinvestor_presentation
51 Pages
Iovance Biotherapeutics Investor Presentation — March 2021
investor_presentationinvestor_presentation
51 Pages
Iovance Biotherapeutics Investor Presentation — April 2021
investor_presentationinvestor_presentation
51 Pages
Iovance Biotherapeutics Investor Presentation — June 2021
investor_presentationinvestor_presentation
30 Pages
Iovance Biotherapeutics Investor Presentation — November 2021
investor_presentationinvestor_presentation
34 Pages
Iovance Biotherapeutics Investor Presentation — November 2021
investor_presentationinvestor_presentation
50 Pages
Iovance Biotherapeutics Investor Presentation — May 2022
investor_presentationinvestor_presentation
32 Pages